Mineralys Therapeutics, Inc. · NASDAQ:MLYS
Warren Eric sold 7,438 Mineralys Therapeutics, Inc. shares (Form 4)
Traded Sep 21, 2026 · Filed Sep 22, 2026
On Sep 21, 2026, Warren Eric (Chief Commercial Officer) sold 7,438 Mineralys Therapeutics, Inc. shares at US$28.12 for US$209K under a trading plan, leaving 38,400 shares. Filed Sep 22, 2026 (Form 4).
- Sold
- 7,438 shares
- Price
- US$28.12
- Value
- US$209K
- Holding after
- 38,400 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Commercial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 21, 2026 | Common Stock | Option exercise | 7,438 | US$13.24 | 45,838 | Direct |
| Sep 21, 2026 | Common Stock | Sale | 7,438 | US$28.12 | 38,400 | Direct |
Source
Related
- Mineralys Therapeutics, Inc.
- Warren Eric
- Mineralys Therapeutics, Inc. shareholders
- Form 4 · Warren Eric · Aug 25, 2026
- Form 4 · Warren Eric · Jul 23, 2026
- Form 4 · Warren Eric · Jun 30, 2026
- Form 4 · Congleton Jon · Oct 2, 2026
- Form 4 · Slingsby Brian Taylor · Sep 24, 2026
- Form 4 · Karydas Daphne · Sep 17, 2026
- Form 4 · Ferguson James J. III · Aug 12, 2026
- Form 4 · Rodman David Malcom · Aug 12, 2026